TECRL and catecholaminergic polymorphic ventricular tachycardia: These investigations will validate the genotype-phenotype correlation, elucidate the molecular pathophysiology of TECRL-deficient CPVT, and provide platforms for developing targeted therapies, while also improving genetic counseling for affected families.